Atlas of Imaging in Cardio-Oncology: Case-Based Study Guide
Editat de Richard M. Steingart, Jennifer E. Liuen Limba Engleză Paperback – 5 aug 2022
Atlas of Imaging in Cardio-Oncology enables the reader to develop a deep understanding of how to utilise a variety of imaging modalities used in cardio-oncology in a range of scenarios. It provides a critical and timely resource for the trainee and experienced cardiologist, oncologist and radiologist.
| Toate formatele și edițiile | Preț | Express |
|---|---|---|
| Paperback (1) | 1273.41 lei 6-8 săpt. | |
| Springer International Publishing – 5 aug 2022 | 1273.41 lei 6-8 săpt. | |
| Hardback (1) | 1782.32 lei 3-5 săpt. | |
| Springer International Publishing – 4 aug 2021 | 1782.32 lei 3-5 săpt. |
Preț: 1273.41 lei
Preț vechi: 1340.43 lei
-5% Nou
Puncte Express: 1910
Preț estimativ în valută:
243.75€ • 255.88$ • 201.35£
243.75€ • 255.88$ • 201.35£
Carte tipărită la comandă
Livrare economică 30 ianuarie-13 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783030710002
ISBN-10: 3030710009
Pagini: 316
Ilustrații: XIV, 316 p. 301 illus., 259 illus. in color.
Dimensiuni: 210 x 279 mm
Greutate: 0.82 kg
Ediția:1st ed. 2021
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland
ISBN-10: 3030710009
Pagini: 316
Ilustrații: XIV, 316 p. 301 illus., 259 illus. in color.
Dimensiuni: 210 x 279 mm
Greutate: 0.82 kg
Ediția:1st ed. 2021
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland
Cuprins
Multimodality Imaging in Cardio-Oncology.- Anthracycline/Trastuzumab Cardiac Toxicity.- Immune Checkpoint Inhibitor (ICI)-Associated Myocarditis.- Cardiovascular Events After Chimeric Antigen Receptor T-Cell Therapy.- Introduction to Tyrosine Kinase Inhibitors: Pazopanib Cardiotoxicity.- Tyrosine Kinase Inhibitors: Arrhythmias and Coagulopathy.- Vascular Toxicity of Tyrosine Kinase Inhibitors: Peripheral Vascular and Coronary Artery Disease.- Vascular Toxicity of Tyrosine Kinase Inhibitors: Coronary Artery Disease.- Vascular Toxicity of Tyrosine Kinase Inhibitors: Pulmonary Hypertension.- Cardiovascular Toxicities of Proteasome Inhibitors.- Cardiac Complications of 5-Flourouracil (5FU) and Capecitabine Therapy.- Cisplatin and Carboplatin.- Cardiac Risk Assessment Prior to Hematopoietic Stem Cell Transplantation: Cases and Management Strategies.- The Role of Myocardial Perfusion Imaging in Cardiac Clearance of Cancer Patients.- Perioperative Management of the Cancer Patient.- Masses Involving the Heart and Vasculature.- Carcinoid Heart Disease.- Cardiac Amyloidosis.- Stress-induced Cardiomyopathy.- Arterial Thrombosis: Marantic Endocarditis.- Pericardial Effusion, Tamponade, and Constrictive Pericarditis.- Introduction to the Cardiac Implications of Radiotherapy.- Cardio-Oncologists’ Perspective on the Cardiac Implications of Radiotherapy: Complex Cases of Radiation-related Valvular and Vascular Disease.- Radiation-related Coronary and Conduction System Disease.- Radiation Injury to the Heart, Great Vessels, and Their Branches.- Cardiac Constriction and Restriction After Chest Radiotherapy for Hodgkin’s Lymphoma and Breast Cancer.- Onset of Heart Failure After Anthracycline Therapy in the Adult: Treatment and Expectations for Recovery.- Heart Failure in Long-term Survivors of Childhood or Adolescent Cancers.- Health Care Disparities in Cardio-Oncology.- Cardio-Oncology Practice in the Community.- Cardio-Oncology in the COVID-19 Era.- Acute Cardiac Care of Cancer Patients.
Notă biografică
Richard M. Steingart
With more than 25 years of experience as a clinician, researcher, and educator in cardiovascular diseases, Dr Steingart joined Memorial Sloan Kettering as Chief of the Cardiology Service in 2003. MSK’s Cardiology Service is one of the world’s leading programs devoted exclusively to the management of cardiovascular diseases in cancer patients. The many facets of this program share a common goal: to facilitate the delivery of optimal cancer therapy in patients who are at risk for or who have existing heart disease. Careful communication with other members of the MSK treatment team — including oncologists, surgeons, radiologists, radiation therapists, and medical subspecialists — makes this possible. On a practical level, this effort reduces the risk of cancer patients developing heart disease, and allows more patients who have both cancer and heart disease to safely receive the optimal therapy for their cancer.
With more than 25 years of experience as a clinician, researcher, and educator in cardiovascular diseases, Dr Steingart joined Memorial Sloan Kettering as Chief of the Cardiology Service in 2003. MSK’s Cardiology Service is one of the world’s leading programs devoted exclusively to the management of cardiovascular diseases in cancer patients. The many facets of this program share a common goal: to facilitate the delivery of optimal cancer therapy in patients who are at risk for or who have existing heart disease. Careful communication with other members of the MSK treatment team — including oncologists, surgeons, radiologists, radiation therapists, and medical subspecialists — makes this possible. On a practical level, this effort reduces the risk of cancer patients developing heart disease, and allows more patients who have both cancer and heart disease to safely receive the optimal therapy for their cancer.
Jennifer E. Liu
Dr. Liu is the Director of the Cardiovascular Laboratories at Memorial Sloan Kettering Cancer Center. She has more than 20 years of experience in echocardiography and is a recognized leader in the field of cardiovascular imaging in Cardio Oncology. As an author of key expert consensus documents, she is dedicated to setting the standard of practice on the contemporary use of echocardiography in the management of patients during and after cancer therapy. Her clinical and research interests include the development of imaging-based strategies for early diagnosis and management of cardiotoxicity to optimize cardiovascular health in patients with cancer. She is the founder of the annual MSK Cardio Oncology symposium which provides a case-based curriculum to educate clinicians involved in the care of cancer patients.
Textul de pe ultima copertă
This atlas provides a practically applicable didatic case-based guide to the use of cardiac imaging in patient care during and after cancer therapy. It features detailed information on a variety of imaging modalities, including transesophageal echocardiography, magnetic resonance angiography and positron emission tomography. A range of actual patient presentations are included covering both diagnosis and management during curative and palliative surgery, as well as cancer pharmacotherapy with the use of drugs including Trastuzumab, Anthracycline, Cisplatin and Carboplatin. Topics relevant to survivorship are also described.
Atlas of Imaging in Cardio-Oncology enables the reader to develop a deep understanding of how to utilise a variety of imaging modalities used in cardio-oncology in a range of scenarios. It provides a critical and timely resource for the trainee and experienced cardiologist, oncologist and radiologist.
Atlas of Imaging in Cardio-Oncology enables the reader to develop a deep understanding of how to utilise a variety of imaging modalities used in cardio-oncology in a range of scenarios. It provides a critical and timely resource for the trainee and experienced cardiologist, oncologist and radiologist.
Caracteristici
Provides a number of real world case-based scenarios to reveal the clinical subtlety of imaging cardio-oncology patients
Collection of case studies presented by practitioners from around the globe to give readers an international perspective on the practice of cardio-oncology
Assists teaching in the area with the use of didactic clinical review questions and answers
Contains a wealth of informative figures and video material
Collection of case studies presented by practitioners from around the globe to give readers an international perspective on the practice of cardio-oncology
Assists teaching in the area with the use of didactic clinical review questions and answers
Contains a wealth of informative figures and video material